Results

Total Results: 925 records

Showing results for "diabetes".
Users also searched for: diabetes

401. S158 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
     October 01, 2007 - outcome and abstract information on additional potential confounders including obesity, hyperten- sion, diabetes … age (continuous), sex, race (white, black, other), myocardial infarc- tion, congestive heart failure, diabetes … infarction 0.9 0.8–0.9 1.1 0.8–1.5 1.1 0.7–1.5 Congestive heart failure 0.9 0.9–1.0 0.9 0.6–1.3 0.8 0.6–1.3 Diabetes

402. Progestogens for Prevention of Preterm Birth | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/progestogens-preterm-birth/research

403. Comparative Effectiveness of First and Second Generation Antipsychotics in the Adult Population | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antipsychotics-adults/research-protocol

404. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
     January 27, 2014 - The research gap portion is much needed and you may want to consider referencing the 1999 American Diabetes … Consensus Development Conference on Diabetic Foot Wound Care 7-9 April 1999 Boston, Massachusetts Diabetes … Margolis have been found useful for diabetes as well as venous disease.

405. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study … Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes … / Population Harms Related Key Question(s) Interventions Harms Outcomes Behavioral Programs for Diabetes … T1DM, included studies of patients (any age) diagnosed with T1DM and who had undergone basic diabetes … For T2DM, we included studies of adults with T2DM who had undergone basic diabetes education For

406. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
     January 01, 2013 - For example, when studying the association between thiazide diuretics and diabetes, one would presume … that the risk of incident diabetes among the “distant past users” should resemble that of the “nonusers

407. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
     December 04, 2015 - profile has led to great concern, because of the known associations between weight gain and obesity with diabetes … terms of medication-associated adverse effects categorized as major (e.g., mortality, development of diabetes … Development of diabetes mellitus •! Diabetic ketoacidosis ! … diabetes! New6onset!diabetes,!exacerbation!of!previous!diabetes,!diabetic!ketoacidosis,! metabolic!

408. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
     June 01, 2010 - to: • Complications during pregnancy (e.g., allergic reactions or development of gestational diabetes … headache, cough, pain, or irritation at site of administration) • Maternal development of gestational diabetes

409. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
     January 30, 2020 - infarction, cardiac disorders, major vascular event, angina), seizures, stroke, transverse myelitis, diabetes … idiopathic thrombocytopenic purpura, cardiovascular events, seizures, stroke, transverse myelitis, diabetes … Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes … Should adults with diabetes mellitus be vaccinated against hepatitis B virus? … A systematic review of diabetes mellitus and the progression of hepatitis B disease.

410. Comparative Effectiveness of Approaches to Weight Maintenance in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/weight-gain-prevention/research-protocol

411. Future Research Needs for Outcomes of Weight Gain in Pregnancy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/maternal-weight-gain/research

412. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
     October 01, 2010 - Adverse effects of interest include, but are not limited to, glucose intolerance, diabetes, and hypoglycemia … fracture or development of osteoporosis/osteopenia; mortality; glucose measures; and development of diabetes … in five controlled and three single-arm observational studies did not develop glucose intolerance or diabetes … evidence was moderate for the fasting blood glucose evaluation; low for the A1c, glucose intolerance, and diabetes … time period of 6 to 12 months may be insufficient to determine the effect of rhGH on development of diabetes

413. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
     August 12, 2016 - versus other omega-3 supplements, effects of omega-3s on cognition in RCT settings, effects on type 2 diabetes … Major CVD risk factors can also consider diabetes. … Diabetes was considered as an at-risk population. … But diabetes is not a CVD outcome, nor was it considered to be a standard CVD intermediate outcome

414. Appendix-Table-B-1-Observational-Studies (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
     March 20, 2021 - Positive: 46.6 (16.6) Negative: 47.3 (16.3) NR Positive: 242 (48.5) Negatie: 486 (48.8) NR Positive Diabetes … 12 (2.4) Hypertension" 48 (9.6) CPD: 19 (3.8) Cancer: 10 (2.0) Immunodeficiency: 9 (1.8) Negative Diabetes

415. Fiber Intake and Laxation Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-protocol.pdf
     August 15, 2023 - cardiometabolic disease risk o Overweight/obese o Hyperglycemia and related conditions, including type 2 diabetes … cardiometabolic conditions, including overweight/obesity, hyperglycemia and related conditions including type 2 diabetes

416. Kidney-Stones-Draft-Appendi-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
     January 01, 2024 - Obesity Baseline Comorbidity Risk Factors -> Obesity (COMMENT) Baseline Comorbidity Risk Factors -> Diabetes … Baseline Comorbidity Risk Factors -> Diabetes (COMMENT) Baseline Comorbidity Risk Factors -> Gout Baseline … HCTZ 25 mg: 39 /103 (38) HCTZ 50 mg: 33/90 (37) Placebo: 26/97 (27) NA NA Obesity Reports mean BMI Diabetes … stone-free at baseline KMg-citrate: 9 (29) Placebo: 9 (27) Primary hyperparathyroidism NR Obesity NR Diabetes … Placebo: 49 (55) No N (%) stone free at baseline AHA: 12/121 (10) Placebo: 13 /89 (15) NA NA NA NA Diabetes

417. Binge-Eating Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
     December 01, 2015 - Other important targets of treatment include metabolic health (in patients who are obese, have diabetes … disorder and symptoms • Anxiety Physical health and functioning • Obesity • Hypertension • Type 2 diabetes … disorder and symptoms • Anxiety Physical health and functioning • Obesity • Hypertension • Type 2 diabetes … did we find evidence about treatment effectiveness as it relates to final health outcomes such as diabetes … For example, given the prevalence of underlying metabolic disorders (e.g., diabetes mellitus, polycystic

418. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
     August 01, 2013 - subcategories within a broad priority area (e.g., breast cancer, peripheral artery disease, type I diabetes … Diabetes mellitus 8. Functional limitations and disability 9. … affected by a condition and known to have poor health outcomes (e.g., hypertension in African Americans; diabetes … X X X X X X X Diabetes Technology & Therapeutics 1, 4, 5, 7 Monthly journal that publishes scientific … research on new devices, drugs, drug delivery systems, and software for managing patients with diabetes

419. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - cardiovascular deaths, MI or stroke more than same-dose simvastatin monotherapy among patients with diabetes … have added text to clarify that, per the ATP III recommendations; we captured TG for patients with diabetes … Indeed, bile acid sequestrants may lower A1c in those with diabetes and this could be a real advantage … What about harms associated with intensive statin therapy such as diabetes or rhabdomyolysis What … For example, intensive statin therapy has been associated with an increased risk of diabetes compared

420. Childhood Obesity Prevention Programs: Comparative Effectiveness Review and Meta-Analysis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/obesity-child/research